The cblC disease is a rare inborn disorder of the vitamin B12 (cobalamin, Cbl) metabolism characterized by combined methylmalonic aciduria and homocystinuria. The clinical consequences are devastating and, even when early treated with current therapies, the affected children manifest symptoms involving vision, growth, and learning1. The molecular genetic cause of the disease was found in the mutations of the gene coding for MMACHC, a 282 amino acid protein that transports and processes the various forms of Cbl2. Although the crystal structure of the wild-type protein is available3,4, many molecular features of MMACHC physiopathology remain to be understood and a systematic study on the effect of each specific mutation on the resulting protein is still lacking. Here we present the biophysical characterization of wild type MMACHC and a variant, p.R161Q, resulting from the most common missense pathological mutation found in CblC patients. By using a biophysical approach, we investigated the stability of the two proteins and their ability to bind and transform the vitamin B125, and to assemble in a dimeric structure. Moreover, we evaluated whether drug-like molecules identified by computational methods, or non-specific stabilizers (osmolytes) could restore the functionality in MMACHC mutant. Overall, our results reveal how a biophysical approach based on the complementarity of computational and experimental methods can offer new insights in the study of the specific effects of the pathological cblC mutation and help prospecting new routes for the cblC treatment.

Lisa Longo, Rita Carrotta, Maria Assunta Costa, Rosa Passantino, Maria Rosalia Mangione, Loredana Randazzo, et al. (2024). INVESTIGATION ON MMACHC-R161Q PATHOLOGICAL MUTANT FROM cblC DISEASE, A RARE METABOLIC DISORDER OF VITAMIN B12 METABOLISM. In Libro degli abstract XXVII Congressso Nazionale SIBPA 2024.

INVESTIGATION ON MMACHC-R161Q PATHOLOGICAL MUTANT FROM cblC DISEASE, A RARE METABOLIC DISORDER OF VITAMIN B12 METABOLISM

Lisa Longo;Rita Carrotta;Rosa Passantino;Maria Rosalia Mangione;Loredana Randazzo;Marco Tutone;Vincenzo Martorana;
2024-06-01

Abstract

The cblC disease is a rare inborn disorder of the vitamin B12 (cobalamin, Cbl) metabolism characterized by combined methylmalonic aciduria and homocystinuria. The clinical consequences are devastating and, even when early treated with current therapies, the affected children manifest symptoms involving vision, growth, and learning1. The molecular genetic cause of the disease was found in the mutations of the gene coding for MMACHC, a 282 amino acid protein that transports and processes the various forms of Cbl2. Although the crystal structure of the wild-type protein is available3,4, many molecular features of MMACHC physiopathology remain to be understood and a systematic study on the effect of each specific mutation on the resulting protein is still lacking. Here we present the biophysical characterization of wild type MMACHC and a variant, p.R161Q, resulting from the most common missense pathological mutation found in CblC patients. By using a biophysical approach, we investigated the stability of the two proteins and their ability to bind and transform the vitamin B125, and to assemble in a dimeric structure. Moreover, we evaluated whether drug-like molecules identified by computational methods, or non-specific stabilizers (osmolytes) could restore the functionality in MMACHC mutant. Overall, our results reveal how a biophysical approach based on the complementarity of computational and experimental methods can offer new insights in the study of the specific effects of the pathological cblC mutation and help prospecting new routes for the cblC treatment.
giu-2024
Settore CHEM-07/A - Chimica farmaceutica
Lisa Longo, Rita Carrotta, Maria Assunta Costa, Rosa Passantino, Maria Rosalia Mangione, Loredana Randazzo, et al. (2024). INVESTIGATION ON MMACHC-R161Q PATHOLOGICAL MUTANT FROM cblC DISEASE, A RARE METABOLIC DISORDER OF VITAMIN B12 METABOLISM. In Libro degli abstract XXVII Congressso Nazionale SIBPA 2024.
File in questo prodotto:
File Dimensione Formato  
AbstractSIBPA24_LisaLongo.pdf

accesso aperto

Descrizione: Abstract intervento XXVII Congresso Nazionale SIBPA 2024
Tipologia: Versione Editoriale
Dimensione 209.02 kB
Formato Adobe PDF
209.02 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/642253
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact